Orion, Mylan settle patent dispute over Parkinson's drug Stalevo
HELSINKI (Reuters) - Finnish drug maker Orion said that it settled a patent lawsuit in the United States against Mylan Pharmaceuticals over Mylan's application to sell a generic version of Orion's Parkinson's drug Stalevo.
Orion did not disclose the terms of their settlement, but said Mylan would be authorized to launch generic versions of the Stalevo drug.
(Reporting by Ritsuko Ando; editing by Keiron Henderson)
- Malaysia Airlines plane missing at sea off Vietnam, presumed crashed |
- China draws 'red line' on North Korea, says won't allow war on peninsula
- Malaysian plane crashed off Vietnam coast: state media
- Fresh confrontations raise tempers on ground in Crimea |